MDPI World Hepatitis Day Webinar 2024
Welcome Message
MDPI is launching a special webinar to encourage researchers to come together, take action, and raise awareness about the global burden of viral hepatitis and the importance of a united effort to eliminate it.
Viral hepatitis is a major global health challenge, affecting millions of people worldwide, causing both acute and chronic disease, and resulting in 1.4 million deaths every year. With 296 million people living with chronic hepatitis B and 58 million people with chronic hepatitis C, raising awareness and driving global efforts for prevention, testing, and treatment is crucial.
We are very much looking forward to seeing you at the MDPI World Hepatitis Day Webinar 2024
Date: 29 July 2024
Time: 03:00pm CEST | 09:00 pm CST (Asia)
Webinar ID: 859 9587 0115
Webinar Secretariat: journal.webinar@mdpi.com
Keynote Speakers
Infectious Diseases Translational Research Programme and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Delineating the roles of Hepatitis B viral proteins in mediating viral replication and pathogenesis
A/Prof Yee-Joo TAN is trained in protein chemistry as well as virology and has been doing research on hepatitis viruses, influenza viruses as well as newly emerged viruses. Her laboratory uses both in vitro and in vivo experiments to understand the molecular mechanisms for viral-host interactions and adaptive immune responses to viral infection. She also studies the conservation of antibody epitopes in viral proteins as this has implication for the development of diagnostic assays.
Division of Gastroenterology- Hepatology, IRCCS Fondazione Ca' Granda Policlinico, Milan, MI, Italy
WHO call for eradicating hepatitis C and B: micro elimination strategies, initial results and open issues
Dr. Giuseppe Colucci, graduated in medicine and surgery and specialized in liver and metabolic diseases at the University of Milan, Italy, developed his clinical and scientific skills also in the area of Gastroenterology through a period of 6 years spent in New York at the Mount Sinai School of Medicine and Cornell University Medical College as research fellow and assistant professor. Dr. Colucci has been involved in clinical and basic research, also collaborating with the main pharmaceutical companies active in the field, including Baxter and Hoffman La Roche. Currently, he coordinates several clinical research projects at the IRCCS Fondazione Ca' Granda Policlinico of Milan, Italy. In particular, the multicenter European project, VH COMSAVAC, on the screening and linkage to care of populations at risk of being asymptomatic carriers of hepatitis C and B. He is the author of more than 100 scientific publications in international peer review journals and active in clinical practice at his own clinic and as consultant at other gastroenterology-liver units. He is also senior medical advisor at the Department of Global Support,Roche Diagnostic International Ltd, Rotkreuz, Switzerland.
Elimination of Hepatitis C: Last Mile
Chia-Yen Dai, M.D, Ph.D. graduated from College of Medicine, Kaohsiung Medical University, completed his clinical training in Kaohsiung Medical University Hospital, and MD and a Ph.D. degree in Kaohsiung Medical University, Kaohsiung, Taiwan. He is now (1) Professor of College of Medicine, Kaohsiung Medical University; (2) Vice Superintendent of Kaohsiung Medical University Hospital (3) Visiting staff of Hepatology Division, Department of Internal Medicine, Kaohsiung Medical University Hospital. (4) Director of Taiwan Liver Cancer Association (TLCA) (5) Director of Gastroenterology Society of Taiwan (GEST). (6) The Chief Medical Supervisor of the Taiwan Liver Research Foundation. He was previously the Director of the Hepatitis Center, Gastroenterology Center, the Department of Occupational and Environmental Medicine, Department of Preventive Medicine, Department of Community Medicine, and Medical Secretary of Kaohsiung Medical University Hospital, the Secretary General, Vice President of the Office of Library and Information Services and the Director of Director of Human Resources Office of Kaohsiung Medical University, the Vice Secretary-General of both GEST and Taiwan Association of the Study of the Liver (TASL). He has the National Medical Board, Board of Internal Medicine, Board of Gastroenterology, Board of Digestive Endoscopy, Board of Taiwan Society of Ultrasound in Medicine, Board of Occupational Medicine, and Board of Liver cancer. The major fields of research include the natural course, virology, and management of chronic viral hepatitis B and C and hepatocellular carcinoma and related human genomics and occupational and environmental medicine. He has published more than 430 peer-reviewed papers, with more than 70 papers as the first author. He sits on the editorial boards of international journals and serves as a reviewer for many scientific journals.
Webinar Recording
Program
|
Speaker |
Time in CEST |
Time in CST (Asia) |
|
Host |
3:00 - 3:10 pm |
9:00 – 9:10 pm |
|
Assoc. Prof. Yee-Joo Tan |
3:10 - 3:40 pm |
9:10 – 9:40 pm |
|
Dr. Giuseppe Colucci WHO Call for Eradicating Hepatitis C and B: Micro Elimination Strategies, Initial Results and Open Issues
|
3:40 - 4:10 pm |
9:40 – 10:10 pm |
|
Prof. Dr. Chia-Yen Dai Elimination of Hepatitis C: Last Mile |
4:10 - 4:40 pm |
10.10 - 10.40 pm |
|
Q&A Session |
4:40 - 4:50 pm |
10:40 – 10:50 pm |
|
Host Closing of Webinar |
4:50 - 5:00 pm |
10:50 – 11:00 pm |
Relevant Special Issues
Animals
Diseases of the Small and Large Intestine, Liver and Pancreas in Small Animals: Second Edition
Edited by Dr. Alessio Pierini and Dr. Eleonora Gori
Deadline for submission: 20 December 2024
Metabolic Disorders of Poultry
Edited by Dr. Victoria Anthony Uyanga and Dr. Felix Kwame Amevor
Deadline for submission: 28 February 2025
Cancers
Hepatitis Viruses and Cancer
Edited by Prof. Dr. John Koskinas and Dr. Urania Georgopoulou
Deadline for submission: 1 November 2024
Cells
Interdisciplinary Approaches to Studying Human Liver Biology and Promoting Organ Regeneration: Understanding the Curse of Prometheus
Edited by Prof. Dr. David C. Hay, Dr. Matthew Sinton and Alvile Kasarinaite
Deadline for submission: N.A.
Children
Old and New Therapeutic Strategies in Children with Liver Disease
Edited by Dr. Raffaele Iorio and Dr. Fabiola Di Dato
Deadline for submission: 30 September 2024
Diagnostics
Diagnosis, Management, and Prognosis of Liver Disease and Its Syndromes
Edited by Prof. Dr. Chien Hao Huang
Deadline for submission: 31 August 2024
Diagnostic and Prognostic Markers in Liver Diseases
Edited by Dr. Dávid Tornai
Deadline for submission: 31 October 2024
Diagnosis of Liver Disease
Edited by Dr. Sung-Eun Kim
Deadline for submission: 31 December 2024
Gastroenterology Insights
Novelties in Diagnostics and Therapeutics in Hepatology: 2nd Edition
Edited by Dr. Giovanni Marasco and Dr. Matteo Renzulli
Deadline for submission: 31 December 2024
Journal of Personalized Medicine
Chronic Liver Disease: New Targets and New Mechanisms
Edited by Dr. Theodoros Androutsakos
Deadline for submission: 20 February 2025
Livers
Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment
Edited by Prof. Dr. Ralf Weiskirchen and Prof. Dr. Tilman Sauerbruch
Deadline for submission: 20 December 2024
Medicina
Editorial Board Members’ Collection Series: Gastrointestinal and Hepatic Diseases
Edited by Prof. Dr. Ludovico Abenavoli and Dr. Marcello Candelli
Deadline for submission: 24 December 2024
Advances in Liver Surgery
Edited by Prof. Dr. Jai Young Cho
Deadline for submission: 24 December 2024
Novelties in Chronic Liver Diseases
Edited by Prof. Dr. Ludovico Abenavoli
Deadline for submission: 30 September 2024
Metabolites
Research on Pharmacotherapy of Metabolic-Associated Fatty Liver Disease
Edited by Dr. Aleksandra Bołdys
Deadline for submission: 30 September 2024
Metabolic Syndrome and Non-alcoholic Liver Disease
Edited by Prof. Dr. Mircea-Catalin Fortofoiu, and Dr. Luigi Boccuto
Deadline for submission: 20 October 2024
Liver Injury and Regeneration—Metabolic Research
Edited by Dr. Miguel Suárez Matías
Deadline for submission: 31 December 2024
Microorganisms
Hepatitis B Virus Infection and Vaccine
Edited by Dr. Nishi N. Prabdial-Sing
Deadline for submission: 15 December 2024
Nutrients
Metabolic-Dysfunction-Associated Steatotic Liver Disease at the Forefront: Confronting Nutritional Obstacles in Advanced Chronic Liver Disease and Portal Hypertension
Edited by Dr. Angelo Armandi and Dr. Federico Ravaioli
Deadline for submission: 15 October 2024
Prevention and Treatment of Liver Diseases by Dietary Habits and Lifestyle
Dr. Marica Cariello and Dr. Raffaella Maria Gadaleta
Deadline for submission: 15 December 2024
Managing Nonalcoholic Fatty Liver Disease with Nutrition
Edited by Dr. Nobuyuki Toshikuni
Deadline for submission: 25 December 2024
Pathogens
Zoonotic Hepatitis E Virus: A Focus on Animals, Food and Environment
Edited by Prof. Dr. Barbara Di Martino, Dr. Federica Di Profio and Dr. Andrea Palombieri
Deadline for submission: 10 October 2024
Vaccines
Vaccines and Vaccination: HIV, Hepatitis Viruses, and HPV
Edited by Dr. Ivan Schietroma and Dr. Sonia Moretti
Deadline for submission: 28 February 2025
Vaccination and Treatments against Viral Hepatitis: Achievements, Challenges and Perspectives
Edited by Dr. Bárbara Vieira Do Lago and Dr. Vinicius M. Mello
Deadline for submission: 15 March 2025
Sponsors and Partners
Organizers
